Vaccinex Price on December 20, 2024

VCNXDelisted Stock  USD 1.09  0.01  0.91%   
If you're considering investing in Vaccinex Stock, it is important to understand the factors that can impact its price. As of today, the current price of Vaccinex stands at 1.09, as last reported on the 3rd of January, with the highest price reaching 1.20 and the lowest price hitting 1.07 during the day. Vaccinex owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0191, which indicates the firm had a -0.0191% return per unit of risk over the last 3 months. Vaccinex exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Vaccinex's Variance of 149.34, risk adjusted performance of (0.04), and Coefficient Of Variation of (1,705) to confirm the risk estimate we provide.
  
Vaccinex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0191

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVCNX

Estimated Market Risk

 12.78
  actual daily
96
96% of assets are less volatile

Expected Return

 -0.24
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average Vaccinex is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaccinex by adding Vaccinex to a well-diversified portfolio.

Related Headline

Monopar Therapeutics Headline on 20th of December 2024

WILMETTE, Ill., Dec. 20, 2024 -- Monopar Therapeutics Inc. , a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today announced the pricing of an underwritten registered offering of 798,655 shares of its common stock at an offering price of 23.79 per share. In addition to the shares sold in the registered offering, Monopar announced the concurrent pricing of a priva

Vaccinex Valuation on December 20, 2024

It is possible to determine the worth of Vaccinex on a given historical date. On December 20, 2024 Vaccinex was worth 1.09 at the beginning of the trading date compared to the closed value of 1.21. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Vaccinex stock. Still, in general, we apply an absolute valuation method to find Vaccinex's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Vaccinex where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Vaccinex's related companies.
 Open High Low Close Volume
  1.00    1.14    0.76    1.01    50,880  
12/20/2024
  1.09    1.36    1.00    1.21    28,741  
  1.21    1.40    1.21    1.31    15,525  
Backtest Vaccinex  |  Vaccinex History  |  Vaccinex Valuation   PreviousNext  
Open Value
1.09
1.21
Closing Value
39.44
Upside

Vaccinex Trading Date Momentum on December 20, 2024

On December 23 2024 Vaccinex was traded for  1.31  at the closing time. The top price for the day was 1.40  and the lowest listed price was  1.21 . The trading volume for the day was 15.5 K. The trading history from December 23, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 8.26% . The trading price change against the current closing price is 9.09% .

Vaccinex Fundamentals Correlations and Trends

By evaluating Vaccinex's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Vaccinex's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Vaccinex financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Vaccinex Stock history

Vaccinex investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Vaccinex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Vaccinex will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Vaccinex stock prices may prove useful in developing a viable investing in Vaccinex
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on treating cancer and neurodegenerative disease through the inhibition of semaphorin 4D . Vaccinex, Inc. was incorporated in 2001 and is headquartered in Rochester, New York. Vaccinex operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people.

Vaccinex Stock Technical Analysis

Vaccinex technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Vaccinex technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Vaccinex trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Vaccinex Period Price Range

Low
January 3, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Vaccinex cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Vaccinex January 3, 2025 Market Strength

Market strength indicators help investors to evaluate how Vaccinex stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Vaccinex shares will generate the highest return on investment. By undertsting and applying Vaccinex stock market strength indicators, traders can identify Vaccinex entry and exit signals to maximize returns

Vaccinex Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Vaccinex's price direction in advance. Along with the technical and fundamental analysis of Vaccinex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Vaccinex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaccinex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Vaccinex Stock

If you are still planning to invest in Vaccinex check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Vaccinex's history and understand the potential risks before investing.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Transaction History
View history of all your transactions and understand their impact on performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Volatility Analysis
Get historical volatility and risk analysis based on latest market data